Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 230 results.

Thumbnail for Oral Azacitidine Maintenance vs Observation in Acute Myeloid Leukemia in First Remission: A Systematic Review and Pooled Analysis of Randomized Evidence

AML - 301

Oral Azacitidine Maintenance vs Observation in Acute Myeloid Leukemia in First Remission: A Systematic Review and Pooled Analysis of Randomized Evidence

Elias Tayar

Poster Presenter: Elias Tayar

Thumbnail for Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

AML - 327

Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

Gautam Pantwalawalkar

Poster Presenter: Gautam Pantwalawalkar

Thumbnail for Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

AML - 336

Widening Racial and Urban-Rural Disparities in AML Mortality in the Targeted Therapy Era: A Population-Level Analysis of US Mortality Trends, 2018-2024

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent-Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy an

AML - 347

MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent-Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy an

Nikolaos Spyrou

Poster Presenter: Nikolaos Spyrou

Thumbnail for Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

AML - 350

Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

Vidushi Reddy Gillela

Poster Presenter: Vidushi Reddy Gillela

Thumbnail for Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

AML - 357

Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

Tareq Abuasab

Poster Presenter: Tareq Abuasab

Thumbnail for Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

AML - 372

Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

Fnu Sumia

Poster Presenter: Fnu Sumia

Thumbnail for Lineage-Specific CK2α Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

AML - 377

Lineage-Specific CK2α Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

Yasin Uzun

Poster Presenter: Yasin Uzun

Thumbnail for Venetoclax?in Combination With?a Hypomethylating Agent for Patients With?Newly Diagnosed Acute Myeloid Leukemia Who Are?Medically?Unfit for Intensive Induction Therapy: A Real-World Community Experience

AML - 384

Venetoclax?in Combination With?a Hypomethylating Agent for Patients With?Newly Diagnosed Acute Myeloid Leukemia Who Are?Medically?Unfit for Intensive Induction Therapy: A Real-World Community Experience

Chiara Perni

Poster Presenter: Chiara Perni

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.